Kirin CVC
VC Fund
Kirin CVC is a corporate venture capital arm of Kirin Holdings Company that focuses on healthcare industries.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Kirin CVC invests in
Stages Kirin CVC invests in
Countries Kirin CVC invests in
Investment Focus
Industry
- Medical 3 (50%)
- Internet 2 (33%)
- Health Care 2 (33%)
- Biotechnology 2 (33%)
- Medical Device 2 (33%)
Stage
- Venture - Series Unknown 3 (50%)
- Series B 2 (33%)
- Series C 1 (17%)
Country
- Japan 4 (67%)
- United States 2 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cala Health
|
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. | Venture - Series Unknown / Mar 25, 2025 | |
MODE
|
With offices in both San Mateo, California, and Tokyo, Japan. The company is rapidly growing with now over fifty employees and is in business to provide end-to-end semi-custom IoT and AI solutions for organizations to improve their operations by connecting them to their data, giving them “real-time” insights, so they can turn innovative ideas intosustainable solutions that address a wide range of challenges.Simple, yet powerful, our latest "next generation" BizStack IoT and BizStack AI solutions are comprised of a continuous improvement technology stack that collects real-time data from any sensor, device, product, equipment, or legacy system. The data is then sanitized, uniquely structured, and provided to highly customizable, intuitive dashboards with powerful insights, along with proper security in the cloud for ongoing IoT and AI applications.BizStack can be deployed 4X faster and 75% less expensively than in-house developers or outside consultants. | $5.2M / Series B / Feb 12, 2025 | |
MOSH Japan
|
MOSH is a web page creation services for individual business owners. | $14.7M / Series C / Feb 05, 2025 | |
BitBiome
|
BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications. | Venture - Series Unknown / Jan 17, 2025 | |
MaRI
|
MaRI develops SAS technologies to solve daily sleep-blocking factors in a human-friendly way. They provide SAS devices to resolve hypopnea and apnea with low-frequency irradiation technology without burdening patients. Their non-contact SAS device also treats illnesses such as heart failure, arrhythmias, stroke, and diabetes. | $2.4M / Series B / Dec 22, 2023 | |
Immunosens
|
Immunological is a developer of electrochemical measurement devices intended to evaluate biomarkers such as genes, proteins, and cell signals using electrode reactions.. The company's product uses disposable printable electrodes in its sensors, thereby providing health-care experts with accurate analysis and measurements in their diagnosis andfood safety inspection tests. | Venture - Series Unknown / Feb 09, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kirin CVC invest in?
Kirin CVC invests primarily in Medical, Internet and Health Care startups, most often at Venture - Series Unknown and Series B stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Kirin CVC last invest?
The most recent investment recorded for Kirin CVC closed in Mar 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
